Package 71610-708-80

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 71610-708-80
Digits Only 7161070880
Product NDC 71610-708
Product ID 71610-708_512751a6-66a2-4ce8-bb22-053853f0300b
Description

180 TABLET, FILM COATED in 1 BOTTLE (71610-708-80)

Marketing

Marketing Status
Marketed Since 2023-05-16
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "512751a6-66a2-4ce8-bb22-053853f0300b", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687"], "spl_set_id": ["b0e10a21-0ae3-4a8b-bd3e-7a48b30f8418"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "180 TABLET, FILM COATED in 1 BOTTLE (71610-708-80)", "package_ndc": "71610-708-80", "marketing_start_date": "20230516"}], "brand_name": "Bupropion Hydrochloride", "product_id": "71610-708_512751a6-66a2-4ce8-bb22-053853f0300b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71610-708", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA076143", "marketing_category": "ANDA", "marketing_start_date": "20060117", "listing_expiration_date": "20261231"}